Cani, Andi K <br/><br/>
Next-Gen Sequencing Exposes Frequent MED12 Mutations and Actionable Therapeutic Targets in Phyllodes Tumors.  [electronic resource] 

 -  Molecular cancer research : MCR  Apr 2015 
 - 613-9 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1557-3125 
<br/><br/><label>Standard No.: </label>10.1158/1541-7786.MCR-14-0578  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Breast Neoplasms--genetics<br/>DNA Copy Number Variations<br/>ErbB Receptors--genetics<br/>Female<br/>Gene Amplification<br/>High-Throughput Nucleotide Sequencing--methods<br/>Humans<br/>Mediator Complex--genetics<br/>Mutation<br/>Neurofibromin 1--genetics<br/>Phyllodes Tumor--genetics<br/>Receptor, IGF Type 1<br/>Receptors, Somatomedin--genetics<br/>Retinoblastoma Protein--genetics<br/>Sequence Analysis, DNA--methods<br/>Tumor Suppressor Protein p53--genetics